西班牙裔代谢功能障碍相关脂肪性肝病成人筛查与风险分层的差异
研究前瞻性纳入244例经活检证实的代谢功能障碍相关脂肪性肝病成人,评估磁共振弹性成像和振动控制瞬时弹性成像在西班牙裔患者中的诊断性能,发现现有非侵入性检查切点在该人群中准确率较低、假阴性率高,并识别出更优切点。
要点
- 西班牙裔患者显著纤维化比例高于非西班牙裔(40% vs 28.4%)。
- 磁共振弹性成像和振动控制瞬时弹性成像在西班牙裔中检测显著纤维化的准确率较低。
- 西班牙裔中低风险纤维化-4指数和低风险振动控制瞬时弹性成像者活检仍见进展期纤维化。
核心结论
- 西班牙裔人群可能需要更低的非侵入性检查切点来优化显著纤维化监测,以匹配其更高的疾病负担和严重程度。
研究设计与样本
- 前瞻性纳入244例经活检证实的代谢功能障碍相关脂肪性肝病成人,进行磁共振弹性成像和振动控制瞬时弹性成像研究访视,组织学和影像学评估集中进行。
主要发现
- 西班牙裔和非西班牙裔患者平均年龄分别为52.6(±13)岁和31.6(±4.6)kg/m²(原文此处表述有矛盾,按上下文应为两组年龄或BMI数据)。
- 40%的西班牙裔患者和28.4%的非西班牙裔患者有显著纤维化。
- 检测显著纤维化时,磁共振弹性成像在西班牙裔与非西班牙裔中的AUROC分别为0.87和0.98(p=0.01),振动控制瞬时弹性成像分别为0.78和0.92(p=0.02)。
- 西班牙裔参与者中,纤维化-4指数低风险者14%活检有进展期纤维化,振动控制瞬时弹性成像低风险者21%活检有进展期纤维化。
关键数值与推荐
- 磁共振弹性成像检测西班牙裔显著纤维化的最佳切点为2.73 kPa。
- 振动控制瞬时弹性成像检测西班牙裔显著纤维化的最佳切点为6.9 kPa。
- 研究结果在拉丁美洲队列中得到验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Cut-points for noninvasive tests for risk stratification in metabolic dysfunction-associated steatotic liver disease were derived from predominantly non-Hispanic populations. It is unknown if these cut-points perform adequately in Hispanic individuals. We assessed the performance characteristics of current noninvasive test cut-points among Hispanic patients and determined whether they could be further optimized. APPROACH AND RESULTS: We prospectively enrolled 244 adults with biopsy-proven metabolic dysfunction-associated steatotic liver disease. Participants underwent a research visit with magnetic resonance elastography (MRE) and vibration-controlled transient elastography (VCTE). Histology and imaging assessments were conducted centrally. Diagnostic performance was evaluated by AUROC and optimal cut-points were identified by Youden J analysis. The mean (±SD) age and body mass index were 52.6 (±13) and 31.6 (±4.6) kg/m 2 . Overall, 40% had diabetes, and 31% (N = 75) were Hispanic. Forty percent of Hispanic and 28.4% of non-Hispanic patients had significant fibrosis. To detect significant fibrosis, MRE and VCTE exhibited significantly lower accuracy in Hispanic versus non-Hispanic participants (AUROC: MRE, 0.87 vs. 0.98, p = 0.01; VCTE, 0.78 vs. 0.92, p = 0.02). Clinical care algorithms yielded high false-negative rates among Hispanic participants (14% with low-risk fibrosis-4 index and 21% with low-risk VCTE had advanced fibrosis on biopsy). Cut-points of 2.73 kPa for MRE and 6.9 kPa for VCTE were optimal for detecting significant fibrosis in Hispanic individuals. Findings were validated in a Latin American cohort. CONCLUSIONS: Lower noninvasive test cut-points may be needed to optimize surveillance for significant fibrosis due to metabolic dysfunction-associated steatotic liver disease in Hispanic populations commensurate with their higher burden and severity of disease.
引用
- Tincopa MA, Díaz LA, Huang DQ, et al. Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease. Hepatology. 2024. PMID: 39423341. doi:10.1097/HEP.0000000000001121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。